GT
ELAN icon

Glenmede Trust’s Elanco Animal Health ELAN Stock Holding History

Glenmede Trust’s Portfolio ELAN Stock Details ELAN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.72M Sell
69,836
-10,735
-13% -$248K 0.01% 623
2026
Q1 		$1.93M Buy
80,571
+11,228
+16% +$274K 0.01% 581
2025
Q4 		$1.57M Buy
+69,343
New +$1.51M 0.01% 617
2025
Q1 		$333K Sell
31,760
-1,222
-4% -$13.8K ﹤0.01% 1045
2024
Q4 		$399K Sell
32,982
-4,956
-13% -$64.8K ﹤0.01% 1012
2024
Q3 		$557K Sell
37,938
-240
-0.6% -$3.34K ﹤0.01% 901
2024
Q2 		$551K Sell
38,178
-6,737
-15% -$108K ﹤0.01% 874
2024
Q1 		$731K Sell
44,915
-4,187
-9% -$65.5K ﹤0.01% 801
2023
Q4 		$732K Sell
49,102
-73,196
-60% -$829K ﹤0.01% 786
2023
Q3 		$1.37M Sell
122,298
-167,764
-58% -$1.95M 0.01% 588
2023
Q2 		$2.73M Hold
290,062
– – 0.02% 473
2023
Q1 		$2.73M Buy
290,062
+162,224
+127% +$1.91M 0.02% 474
2022
Q4 		$1.56M Sell
127,838
-191,397
-60% -$2.39M 0.01% 569
2022
Q3 		$3.96M Sell
319,235
-394,508
-55% -$6.9M 0.03% 416
2022
Q2 		$14M Sell
713,743
-82,765
-10% -$1.96M 0.08% 270
2022
Q1 		$20.8M Sell
796,508
-8,403
-1% -$224K 0.1% 233
2021
Q4 		$22.8M Sell
804,911
-27,941
-3% -$869K 0.11% 221
2021
Q3 		$26.6M Sell
832,852
-2,714
-0.3% -$91.1K 0.14% 178
2021
Q2 		$29M Buy
835,566
+3,233
+0.4% +$107K 0.15% 170
2021
Q1 		$24.5M Buy
832,333
+26,593
+3% +$818K 0.13% 181
2020
Q4 		$24.7M Buy
805,740
+3,756
+0.5% +$115K 0.14% 186
2020
Q3 		$22.4M Buy
801,984
+127,038
+19% +$3.22M 0.13% 178
2020
Q2 		$14.5M Sell
674,946
-132,777
-16% -$2.93M 0.09% 264
2020
Q1 		$23.8M Hold
807,723
– – 0.11% 254
2019
Q4 		$23.8M Sell
807,723
-267,703
-25% -$7.27M 0.11% 254
2019
Q3 		$28.6M Sell
1,075,426
-17,780
-2% -$533K 0.13% 211
2019
Q2 		$36.9M Buy
1,093,206
+510,967
+88% +$16.6M 0.16% 174
2019
Q1 		$18.7M Buy
+582,239
New +$17.9M 0.08% 310

Other funds holding ELAN

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Winslow Capital Management
Winslow Capital Management Minneapolis, Minnesota $29.1B AUM 43.86% 1-Year Est. Return

Glenmede Trust's ELAN Position: Q2 2026 in Review

Glenmede Trust reduced its Elanco Animal Health (ELAN) stake by 13% in Q2 2026, selling an estimated $248K and leaving 69,836 shares worth $1.72M. The position accounts for 0.01% of the portfolio, ranked #623.

Glenmede Trust first reported a position in ELAN in Q1 2019 and has held it in 28 quarters since. The position peaked at $36.9M in Q2 2019. 521 funds tracked by Wall St. Rank hold ELAN as of Q2 2026.

  • Glenmede Trust held 69,836 shares of Elanco Animal Health worth $1.72M as of Q2 2026.
  • Glenmede Trust sold 10,735 Elanco Animal Health shares in Q2 2026, an estimated $248K.
  • Elanco Animal Health made up 0.01% of Glenmede Trust's portfolio in Q2 2026, its #623 holding.
  • Glenmede Trust first reported a position in Elanco Animal Health in Q1 2019 and has held it in 28 quarters since.
  • Glenmede Trust's Elanco Animal Health position peaked at $36.9M in Q2 2019.
  • 521 funds tracked by Wall St. Rank held Elanco Animal Health as of Q2 2026.

Based on Glenmede Trust's 13F filing for Q2 2026, filed 10 Aug 2026.